Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling

• Main Authors: Jiayun Xu (Author), Shanshan Sun (Author), Wei Zhang (Author), Jianhong Dong (Author), Changgang Huang (Author), Xin Wang (Author), Mengxian Jia (Author), Hao Yang (Author), Yongjie Wang (Author), Yuanyuan Jiang (Author), Liying Cao (Author), Zhihui Huang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Glioblastoma (GBM) is the most malignant glioma in brain tumors with low survival and high recurrence rate. Irigenin, as an isoflavone compound extracted from Shegan, has shown many pharmacological functions such as antioxidant, anti-inflammatory and anti-tumor. However, the effects of irigenin on G...